Copyright Reports & Markets. All rights reserved.

COVID-19 Impact on Global Artemisinin Derivatives, Market Insights and Forecast to 2026

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Artemisinin Derivatives Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Artemisinin Derivatives Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Artemisinin Derivatives Market Size Growth Rate by Type
    • 1.4.2 Dihydroartemisinin
    • 1.4.3 Artemisunate
    • 1.4.4 Others
  • 1.5 Market by Application
    • 1.5.1 Global Artemisinin Derivatives Market Size Growth Rate by Application
    • 1.5.2 Malaria Treatment
    • 1.5.3 Scientific Research
    • 1.5.4 Others
  • 1.6 Coronavirus Disease 2019 (Covid-19): Artemisinin Derivatives Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Artemisinin Derivatives Industry
      • 1.6.1.1 Artemisinin Derivatives Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Artemisinin Derivatives Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Artemisinin Derivatives Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Executive Summary

  • 2.1 Global Artemisinin Derivatives Market Size Estimates and Forecasts
    • 2.1.1 Global Artemisinin Derivatives Revenue 2015-2026
    • 2.1.2 Global Artemisinin Derivatives Sales 2015-2026
  • 2.2 Artemisinin Derivatives Market Size by Region: 2020 Versus 2026
    • 2.2.1 Global Artemisinin Derivatives Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Artemisinin Derivatives Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Artemisinin Derivatives Competitor Landscape by Players

  • 3.1 Artemisinin Derivatives Sales by Manufacturers
    • 3.1.1 Artemisinin Derivatives Sales by Manufacturers (2015-2020)
    • 3.1.2 Artemisinin Derivatives Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Artemisinin Derivatives Revenue by Manufacturers
    • 3.2.1 Artemisinin Derivatives Revenue by Manufacturers (2015-2020)
    • 3.2.2 Artemisinin Derivatives Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Artemisinin Derivatives Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Artemisinin Derivatives Revenue in 2019
    • 3.2.5 Global Artemisinin Derivatives Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Artemisinin Derivatives Price by Manufacturers
  • 3.4 Artemisinin Derivatives Manufacturing Base Distribution, Product Types
    • 3.4.1 Artemisinin Derivatives Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Artemisinin Derivatives Product Type
    • 3.4.3 Date of International Manufacturers Enter into Artemisinin Derivatives Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Artemisinin Derivatives Market Size by Type (2015-2020)
    • 4.1.1 Global Artemisinin Derivatives Sales by Type (2015-2020)
    • 4.1.2 Global Artemisinin Derivatives Revenue by Type (2015-2020)
    • 4.1.3 Artemisinin Derivatives Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Artemisinin Derivatives Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Artemisinin Derivatives Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Artemisinin Derivatives Revenue Forecast by Type (2021-2026)
    • 4.2.3 Artemisinin Derivatives Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Artemisinin Derivatives Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Breakdown Data by Application (2015-2026)

  • 5.1 Global Artemisinin Derivatives Market Size by Application (2015-2020)
    • 5.1.1 Global Artemisinin Derivatives Sales by Application (2015-2020)
    • 5.1.2 Global Artemisinin Derivatives Revenue by Application (2015-2020)
    • 5.1.3 Artemisinin Derivatives Price by Application (2015-2020)
  • 5.2 Artemisinin Derivatives Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Artemisinin Derivatives Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Artemisinin Derivatives Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Artemisinin Derivatives Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Artemisinin Derivatives by Country
    • 6.1.1 North America Artemisinin Derivatives Sales by Country
    • 6.1.2 North America Artemisinin Derivatives Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Artemisinin Derivatives Market Facts & Figures by Type
  • 6.3 North America Artemisinin Derivatives Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Artemisinin Derivatives by Country
    • 7.1.1 Europe Artemisinin Derivatives Sales by Country
    • 7.1.2 Europe Artemisinin Derivatives Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Artemisinin Derivatives Market Facts & Figures by Type
  • 7.3 Europe Artemisinin Derivatives Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Artemisinin Derivatives by Region
    • 8.1.1 Asia Pacific Artemisinin Derivatives Sales by Region
    • 8.1.2 Asia Pacific Artemisinin Derivatives Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Artemisinin Derivatives Market Facts & Figures by Type
  • 8.3 Asia Pacific Artemisinin Derivatives Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Artemisinin Derivatives by Country
    • 9.1.1 Latin America Artemisinin Derivatives Sales by Country
    • 9.1.2 Latin America Artemisinin Derivatives Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Artemisinin Derivatives Market Facts & Figures by Type
  • 9.3 Central & South America Artemisinin Derivatives Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Artemisinin Derivatives by Country
    • 10.1.1 Middle East and Africa Artemisinin Derivatives Sales by Country
    • 10.1.2 Middle East and Africa Artemisinin Derivatives Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Artemisinin Derivatives Market Facts & Figures by Type
  • 10.3 Middle East and Africa Artemisinin Derivatives Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Sanofi
    • 11.1.1 Sanofi Corporation Information
    • 11.1.2 Sanofi Description, Business Overview and Total Revenue
    • 11.1.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Sanofi Artemisinin Derivatives Products Offered
    • 11.1.5 Sanofi Recent Development
  • 11.2 KPC Pharmaceuticals
    • 11.2.1 KPC Pharmaceuticals Corporation Information
    • 11.2.2 KPC Pharmaceuticals Description, Business Overview and Total Revenue
    • 11.2.3 KPC Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 KPC Pharmaceuticals Artemisinin Derivatives Products Offered
    • 11.2.5 KPC Pharmaceuticals Recent Development
  • 11.3 Guangxi Xiancaotang Pharmaceutical
    • 11.3.1 Guangxi Xiancaotang Pharmaceutical Corporation Information
    • 11.3.2 Guangxi Xiancaotang Pharmaceutical Description, Business Overview and Total Revenue
    • 11.3.3 Guangxi Xiancaotang Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Guangxi Xiancaotang Pharmaceutical Artemisinin Derivatives Products Offered
    • 11.3.5 Guangxi Xiancaotang Pharmaceutical Recent Development
  • 11.4 Guilin Pharmaceutical
    • 11.4.1 Guilin Pharmaceutical Corporation Information
    • 11.4.2 Guilin Pharmaceutical Description, Business Overview and Total Revenue
    • 11.4.3 Guilin Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Guilin Pharmaceutical Artemisinin Derivatives Products Offered
    • 11.4.5 Guilin Pharmaceutical Recent Development
  • 11.5 Kerui Nanhai Pharmaceutical
    • 11.5.1 Kerui Nanhai Pharmaceutical Corporation Information
    • 11.5.2 Kerui Nanhai Pharmaceutical Description, Business Overview and Total Revenue
    • 11.5.3 Kerui Nanhai Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Kerui Nanhai Pharmaceutical Artemisinin Derivatives Products Offered
    • 11.5.5 Kerui Nanhai Pharmaceutical Recent Development
  • 11.6 Shanghai Natural Bio-engineering Co
    • 11.6.1 Shanghai Natural Bio-engineering Co Corporation Information
    • 11.6.2 Shanghai Natural Bio-engineering Co Description, Business Overview and Total Revenue
    • 11.6.3 Shanghai Natural Bio-engineering Co Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Shanghai Natural Bio-engineering Co Artemisinin Derivatives Products Offered
    • 11.6.5 Shanghai Natural Bio-engineering Co Recent Development
  • 11.7 Novanat Bioresource
    • 11.7.1 Novanat Bioresource Corporation Information
    • 11.7.2 Novanat Bioresource Description, Business Overview and Total Revenue
    • 11.7.3 Novanat Bioresource Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Novanat Bioresource Artemisinin Derivatives Products Offered
    • 11.7.5 Novanat Bioresource Recent Development
  • 11.8 Botanical Extracts EPZ Ltd
    • 11.8.1 Botanical Extracts EPZ Ltd Corporation Information
    • 11.8.2 Botanical Extracts EPZ Ltd Description, Business Overview and Total Revenue
    • 11.8.3 Botanical Extracts EPZ Ltd Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 Botanical Extracts EPZ Ltd Artemisinin Derivatives Products Offered
    • 11.8.5 Botanical Extracts EPZ Ltd Recent Development
  • 11.1 Sanofi
    • 11.1.1 Sanofi Corporation Information
    • 11.1.2 Sanofi Description, Business Overview and Total Revenue
    • 11.1.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Sanofi Artemisinin Derivatives Products Offered
    • 11.1.5 Sanofi Recent Development

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Artemisinin Derivatives Market Estimates and Projections by Region
    • 12.1.1 Global Artemisinin Derivatives Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Artemisinin Derivatives Revenue Forecast by Regions 2021-2026
  • 12.2 North America Artemisinin Derivatives Market Size Forecast (2021-2026)
    • 12.2.1 North America: Artemisinin Derivatives Sales Forecast (2021-2026)
    • 12.2.2 North America: Artemisinin Derivatives Revenue Forecast (2021-2026)
    • 12.2.3 North America: Artemisinin Derivatives Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Artemisinin Derivatives Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Artemisinin Derivatives Sales Forecast (2021-2026)
    • 12.3.2 Europe: Artemisinin Derivatives Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Artemisinin Derivatives Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Artemisinin Derivatives Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Artemisinin Derivatives Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Artemisinin Derivatives Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Artemisinin Derivatives Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Artemisinin Derivatives Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Artemisinin Derivatives Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Artemisinin Derivatives Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Artemisinin Derivatives Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Artemisinin Derivatives Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Artemisinin Derivatives Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Artemisinin Derivatives Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Artemisinin Derivatives Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter’s Five Forces Analysis
  • 13.5 Primary Interviews with Key Artemisinin Derivatives Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Artemisinin Derivatives Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source

    Artemisinin Derivatives market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Artemisinin Derivatives market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the Artemisinin Derivatives market is segmented into
    Dihydroartemisinin
    Artemisunate
    Others

    Segment by Application, the Artemisinin Derivatives market is segmented into
    Malaria Treatment
    Scientific Research
    Others

    Regional and Country-level Analysis
    The Artemisinin Derivatives market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Artemisinin Derivatives market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
    Competitive Landscape and Artemisinin Derivatives Market Share Analysis
    Artemisinin Derivatives market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Artemisinin Derivatives business, the date to enter into the Artemisinin Derivatives market, Artemisinin Derivatives product introduction, recent developments, etc.
    The major vendors covered:
    Sanofi
    KPC Pharmaceuticals
    Guangxi Xiancaotang Pharmaceutical
    Guilin Pharmaceutical
    Kerui Nanhai Pharmaceutical
    Shanghai Natural Bio-engineering Co
    Novanat Bioresource
    Botanical Extracts EPZ Ltd

    Buy now